All Articles

UNCF's Project ACCLAIM gives HBCU students $4M investment funds to manage, forging a new pipeline of financial leaders and a model for institutional self-reliance.

With a new $463M war chest and a former Optum CEO on its board, health benefits innovator Gravie is escalating its challenge to the industry establishment.

A startup is using real neurons to discover software that slashes AI costs. We analyze the tech, the market, and the profound implications of this new frontier.

South Korean robotic hand specialist Tesollo targets a post-2027 IPO, fueled by strategic Series B funding and a mission to dominate industrial automation.

As AI floods cybersecurity, Invicti's new Agentic Pentest bets on a hybrid approach, blending AI reasoning with proven tech to find flaws others miss.

Federal Signal's record quarter isn't just a win for Wall Street. It's a sign of surging investment in the essential tools that keep our cities clean and safe.

Nscale's acquisition of Anyscale for a reported $1.65B creates a full-stack AI powerhouse, challenging cloud giants with a vertically integrated platform.

AMG's record Q2 results showcase a masterclass in strategic evolution. A deep dive into alternative investments is fueling massive growth and a disciplined capital return strategy.

Amid record revenues, Martin Marietta's blockbuster deal for Lhoist North America signals a bold pivot beyond construction into industrial minerals.

As Dollar General preps its Q2 earnings, all eyes are on what its results will reveal about inflation, consumer shifts, and the health of the U.S. economy.

A breakthrough in memory from Innodisk promises a 60% speed boost, tackling the bottleneck that slows AI and setting the stage for next-gen computing.

Scorpio Tankers' record Q2 earnings are just the surface. Beneath the windfall lies a masterclass in capital strategy and fleet renewal for a new era.

The luxury outfitter's Q1 results beat expectations, yet a closer look reveals a brand grappling with softening store traffic and a looming trade war.

Knight Therapeutics set a high bar in Q1. As it preps its Q2 results, we look at the strategy and market forces that will define its next chapter.

Cinemark shattered records with its first-ever billion-dollar quarter, proving strategic investments in premium experiences can defy the streaming era.

Regeneron's Q2 results reveal soaring sales from Dupixent and EYLEA HD, a pivotal pipeline, and a major financial reset with Sanofi. What's next?

A single partner default triggers a massive loss at Coastal Financial, testing its high-growth Banking-as-a-Service model and raising questions about hidden risks.

A 5,000km caravan from Wuhan to Kyrgyzstan signals more than a marketing stunt. It's a strategic push by China's automotive heartland to dominate new markets.

A key hire reveals how a legacy bank is leveraging specialized lending and deep community ties to capture one of the nation's most dynamic markets.

A new report reveals a perfect storm: 100% of tested AI apps are vulnerable, logic flaws are exploding, and cloud assets are critically exposed.